Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides

Commentary by Dr. Candice Silversides and Dr. Ashok Krishnaswami

Commentary by Dr. Candice Silversides and Dr. Kamala Tamirisa

Commentary by Dr. Candice Silversides, Dr. Emily Lau, and Dr. Nandita Scott

Alexander Fanaroff, MD, MHS discusses how behavioral economic principles can be used to incentivize healthy behaviors in cardio-oncology. Moderated by Nicholas Wilcox, MD, MHS.

Aarti Asnani, MD discusses anthracyline-induced cardiomyopathy, including risk mitigation strategies, underlying pathogenesis, genetic variants associated with increased risk of this adverse event, and gaps in our understanding. Moderated by Sarah Waliany, MD, MS.

Commentary by Dr. Douglas Mann and Dr. Daniel Burkhoff

Commentary by Drs. Pratik Doshi, Nare Torosyan, current Cardiology Fellow at the Keck School of Medicine of USC, and Janet Wei, the newly minted ACC Southern California Governor and Associate Program Director of Cardiology fellowship at Cedars Sinai Medical Center, sharing their insights from ACC.24 in Atlanta.

Commentary by Dr Yat-Yin Lam

Commentary by Dr Jiang Jun

Audio Summary of the March Issue with Introduction by Dr. Bonnie Ky.

Commentary by Gabriel Aleixo

Commentary by Brian Jensen

Commentary by Saro Armenian

Commentary by Saro Armenian

Commentary by Corralea Kappel

Commentary by Yugo Yamashita

Commentary by Bonnie Ky